Fill out this survey for a FREE sample analysis!
Get a FREE sample analysis! 🧬 Simply complete our short survey, and schedule a time to speak with us about your needs —at no cost. Don’t miss this opportunity! 💡 Start now.
Sign in to Google to save your progress. Learn more
Email *
First Name *
Last Name *
Company or Institution *
Does your company or lab have an area of focus in DNA damage and/or genomic instability? *
If you are a drug-developing company, how many drug candidates do you currently have in different phases of your drug developmental pipeline - including discovery, pre-clinical, clinical, and post-approval stages.  *
0
1
2
3
4
5
5+
Discovery
Pre-clinical
Clinical - Phase 1
Clinical - Phase 2
Clinical - Phase 3
Post-approval
Entering discovery phase in the incoming quarter
How many do you anticipate will enter your pipeline in the next quarter? *
0
1
2
3
4
5
5+
Discovery
Pre-clinical
Clinical - Phase 1
Clinical - Phase 2
Clinical - Phase 3
Post-approval
Entering discovery phase in the incoming quarter
Does your company or lab frequently perform Gentoxicity assays (such as the Ames test, the Mouse Micronucleus test, or the Chromosomal Aberration test)? *
Required
If you answered "Yes" in the previous question, would a deeper probe into the genome-wide mapping of sequences that undergo DNA double-stranded breakage from treatment of cells with your drug candidates or compounds provide additional valuable information? Please explain or provide details. 
BreakSight’s services map and identify genomic sequences that undergo frequent DNA double-strand breakage in cells exposed to treatment(s) that
induces acute DNA damage. Would this technology add value to your company or research to advance drug characterization and gain unique mechanistic insights, or is it similar to existing assays or screens that your company or lab employs? If so, which assay(s) or screen(s)? *
What does your bioinformatics team search for in NGS data? What applications do your company or lab utilize this data for? *
What more would you like to see done to characterize your drug(s) or compounds? (i.e. more in vitro or in vivo studies, greater basic or mechanistic research, expanded biomarker identification, etc.) *
Are there any analytical tools you use that characterize or probe into the role of simple or complex DNA repeats in your research? If not, would such tools be of interest? *
Required
Are there any particular genomic elements or patterns that you are interested in your research? *
Other comments or questions:
A copy of your responses will be emailed to the address you provided.
Submit
Clear form
Never submit passwords through Google Forms.
GoogleForms
reCAPTCHA
PrivacyTerms
This form was created inside of S P.